{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:10:00Z","timestamp":1779171000564,"version":"3.51.4"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"\n Objective<\/jats:title>\n The differentiation between benign pulmonary nodules and early-stage lung cancer remains a significant clinical challenge due to the lack of highly specific non-invasive biomarkers. While the gut-lung axis has emerged as a critical player in pulmonary diseases, the concurrent evolution of oral and gut microbiota across the spectrum from benign nodules to lung cancer remains poorly characterized. This study aimed to investigate the compositional and dynamic changes in oral and gut microbiota across different stages of lung carcinogenesis, with particular emphasis on distinguishing tumor-specific alterations from nodule-related changes by incorporating benign nodules as a critical control group.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n In this retrospective case-control study, we enrolled 111 participants, including healthy controls (C,\n n<\/jats:italic>\n = 36), individuals with benign pulmonary nodules (B,\n n<\/jats:italic>\n = 18), treatment-naive early-stage lung cancer patients (EL,\n n<\/jats:italic>\n = 20), and treatment-naive advanced-stage lung cancer patients (AL,\n n<\/jats:italic>\n = 37). Saliva and fecal samples were collected for 16S rRNA gene sequencing (V3-V4 region). Microbial diversity, community composition, and differential taxa were analyzed using QIIME, LEfSe, and trend tests. Diagnostic efficacy of candidate markers was evaluated by ROC curve analysis.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Lung cancer was associated with significant remodeling of both oral and gut microbiota. While salivary \u03b1-diversity remained stable between groups, gut microbial richness (Chao1 index) was significantly increased in lung cancer patients compared to non-tumor individuals (\n P<\/jats:italic>\n = 0.009). \u03b2-diversity analysis revealed distinct separation in community structure between non-tumor and lung cancer groups for both saliva and feces (\n P<\/jats:italic>\n &lt; 0.01). Trend analysis across the C\u2192 B\u2192 EL\u2192AL continuum demonstrated significant gradient changes: salivary\n Pasteurellaceae<\/jats:italic>\n (primarily\n Haemophilus<\/jats:italic>\n ) and Enterobacterales progressively decreased, while Actinobacteriota,\n Rothia mucilaginosa<\/jats:italic>\n , and\n Prevotella oris<\/jats:italic>\n significantly increased with disease progression. In the gut,\n Veillonellaceae<\/jats:italic>\n and\n Dialister<\/jats:italic>\n gradually declined, whereas\n Bacteroides coprocola<\/jats:italic>\n exhibited a strong positive correlation with disease stage (\u03c1 = 0.84,\n P<\/jats:italic>\n &lt; 0.001). The benign nodule group displayed an intermediate microbial phenotype. Notably,\n R. mucilaginosa<\/jats:italic>\n and\n Haemophilus<\/jats:italic>\n in saliva achieved AUCs of 0.851 and 0.884, respectively, in distinguishing non-tumor individuals from lung cancer patients, while gut\n B. coprocola<\/jats:italic>\n yielded an AUC of 0.901, with maintained discriminatory performance in differentiating benign nodules from early-stage lung cancer.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n Lung cancer progression is accompanied by stage-specific remodeling of the oral-gut microecology. The incorporation of benign nodule controls enables the identification of tumor-specific microbial alterations with high diagnostic efficacy. Salivary\n Rothia mucilaginosa<\/jats:italic>\n and gut\n Bacteroides coprocola<\/jats:italic>\n represent promising non-invasive biomarkers for early lung cancer detection and benign-malignant discrimination, warranting further validation in multicenter prospective cohorts.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1824419","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:44:16Z","timestamp":1779169456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparative study of oral and gut microbiota for differentiating benign pulmonary nodules from lung cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhe","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shupan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Health Service, Guard Bureau of the Joint Staff Department","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Health Service, Guard Bureau of the Joint Staff Department","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Health Service, Guard Bureau of the Joint Staff Department","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Health Service, Guard Bureau of the Joint Staff Department","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Health Service, Guard Bureau of the Joint Staff Department","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota.","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B3","volume-title":"Pulmonary Nodule Risk Prediction Calculators (includes Brock\/PanCan tool guidance context).","year":"2015"},{"key":"B4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","article-title":"Emerging pathogenic links between microbiota and the gut-lung axis.","volume":"15","author":"Budden","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1002\/cam4.5513","article-title":"Screening of potential microbial markers for lung cancer using metagenomic sequencing.","volume":"12","author":"Chen","year":"2023","journal-title":"Cancer Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1513\/AnnalsATS.201803-173CME","article-title":"Models to estimate the probability of malignancy in patients with pulmonary nodules.","volume":"15","author":"Choi","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.21037\/tlcr.2019.09.17","article-title":"Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical population.","volume":"8","author":"Cui","year":"2019","journal-title":"Transl. Lung Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","article-title":"Microbes, metabolites, and the gut-lung axis.","volume":"12","author":"Dang","year":"2019","journal-title":"Mucosal Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume ct screening in a randomized trial.","volume":"382","author":"de Koning","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1038\/s41598-023-29136-4","article-title":"Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit.","volume":"13","author":"Haberman","year":"2023","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","article-title":"Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions.","volume":"102","author":"Lee","year":"2016","journal-title":"Lung Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/diagnostics11030407","article-title":"Microbiota biomarkers for Lung cancer.","volume":"11","author":"Leng","year":"2021","journal-title":"Diagnostics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","article-title":"Lung microbiome: New insights into the pathogenesis of respiratory diseases.","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Target Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"L65","DOI":"10.1152\/ajplung.00421.2020","article-title":"Lung immune tone via gut-lung axis: Gut-derived LPS and short-chain fatty acids\u2019 immunometabolic regulation of lung IL-1\u03b2, FFAR2, and FFAR3 expression.","volume":"321","author":"Liu","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","author":"National Lung Screening Trial Research Team, Aberle","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.medj.2025.100773","article-title":"Microbiota-derived metabolites: Key modulators of cancer immunotherapies.","volume":"6","author":"Perl","year":"2025","journal-title":"Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1158\/1055-9965.EPI-22-0384","article-title":"Comparative microbiomics analysis of antimicrobial antibody response between patients with Lung cancer and control subjects with benign pulmonary nodules.","volume":"32","author":"Shome","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3390\/cells12242801","article-title":"The complex role of the microbiome in non-small cell Lung cancer development and progression.","volume":"12","author":"Souza","year":"2023","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0031423","DOI":"10.1128\/spectrum.00314-23","article-title":"Characterization of Lung and oral microbiomes in lung cancer patients using culturomics and 16S rRNA gene sequencing.","volume":"11","author":"Sun","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-24223-1_1","article-title":"Lung cancer statistics.","volume":"893","author":"Torre","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1289452","DOI":"10.3389\/fcimb.2023.1289452","article-title":"The oral-gut-circulatory axis: From homeostasis to colon cancer.","volume":"13","author":"Tortora","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/jnci\/djac149","article-title":"The oral microbiome and lung cancer risk: An analysis of 3 prospective cohort studies.","volume":"114","author":"Vogtmann","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"B24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.mucimm.2023.11.006","article-title":"Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases.","volume":"17","author":"Yamazaki","year":"2024","journal-title":"Mucosal Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fonc.2018.00520","article-title":"Dysbiosis of the salivary microbiome is associated with non-smoking female Lung cancer and correlated with immunocytochemistry markers.","volume":"8","author":"Yang","year":"2018","journal-title":"Front. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/biomedicines11020631","article-title":"Preliminary study on microbiota characteristics of bronchoalveolar lavage fluid in patients with pulmonary nodules based on metagenomic next-generation sequencing.","volume":"11","author":"Yuan","year":"2023","journal-title":"Biomedicines"},{"key":"B27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12672-023-00748-6","article-title":"Veillonella parvula promotes the proliferation of lung adenocarcinoma through the nucleotide oligomerization domain 2\/cellular communication network factor 4\/nuclear factor kappa B pathway.","volume":"14","author":"Zeng","year":"2023","journal-title":"Discov. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/19490976.2020.1737487","article-title":"Specific gut microbiome signature predicts the early-stage lung cancer.","volume":"11","author":"Zheng","year":"2020","journal-title":"Gut Microbes"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1824419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:44:18Z","timestamp":1779169458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1824419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":28,"alternative-id":["10.3389\/fmicb.2026.1824419"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1824419","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"1824419"}}